PhenobarbitalNeonatal intensive care unitAlthough neonates and young infants with cholestasis are commonly treated with either phenobarbital or ursodeoxycholic acid (ursodiol), there is no evidence that phenobarbital is effective for this indication. Our objective was to compare the effectiveness of ursodiol...
Drug Indication: The drug decreases the absorption of cholesterol and is used to dissolve (cholesterol) gallstones in patients as an alternative to a surgical procedure to remove the gallstones.|FDA Label LiverTox Summary: Ursodeoxycholic acid or ursodiol is a naturally occurring bile acid that is...
Indication Ursodeoxycholic acid is indicated for the treatment of patients with primary biliary cholangitis.9 It is used for the short-term treatment of radiolucent, noncalcified gallbladder stones in patients selected for elective cholecystectomy. It is also used to prevent gallstone formation in obes...
Although neonates and young infants with cholestasis are commonly treated with either phenobarbital or ursodeoxycholic acid (ursodiol), there is no evidence that phenobarbital is effective for this indication. Our objective was to compare the effectiveness of ursodiol and phenobarbital for the treatment of...
Ursodeoxycholic acid (UDCA) is a steroid bile acid with antioxidant, anti-inflammatory activities and has been shown to improve insulin resistance. The current study aims to investigate the effect of UDCA (150 mg/kg) on MS induced in rats by fructose administration (10%) in drinking water for...
Chenodeoxycholic acid is one of the main bile acids.It was first isolated from the bile of the domestic goose, which gives it the "cheno" portion of its name . Indication Chenodeoxycholic acid is a bile acid. Bile acids are steroid acids found pre...
Indication Chenodeoxycholic acid is a bile acid. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on posi...
GOALS: To test whether ursodeoxycholic acid (UDCA) is inhibitory to Clostridium difficile and can be used in the treatment of C. difficile-associated ileal pouchitis. BACKGROUND: The restoration of secondary bile metabolism may be the key mechanism for fecal microbiota transplantation (FMT) in treat...
Pharmacological treatment of biliary cirrhosis with ursodeoxycholic acid IMPORTANCE OF THE FIELD: Primary biliary cirrhosis is a cholestatic liver disease that at one time was the leading indication for liver transplantation. Tr... G Abbas,KD Lindor - 《Expert Opin Pharmacother》 被引量: 35发表: 20...
zincSummary Ursodeoxycholic acid is a naturally occurring secondary bile acid in humans, which suppresses hepatic secretion of cholesterol and inhibits intestinal absorption of cholesterol. When taken therapeutically it greatly increases the interruption of the entero-hepatic recirculation of bile acids. ...